arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

CYPHERPUNK TECHNOLOGIES INC.

CYPH
$0.69 ▲ +0.02 (+2.39%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
42 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
36
Health
Weak
Neutral
auto_awesome

Analytical Summary

CYPHERPUNK TECHNOLOGIES INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $116.0M
Dividend Yield
Revenue Growth None
Op. Margin
ROIC -5.4%
FCF / Share $-0.02
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

42-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$375.00K
— 0.0%
Net Income Profit after all expenses
$-77.17M
↓ -399.9%
FCF / Share Free cash flow per share
$-0.02
↑ +94.2%

Health Breakdown

Returns
50
Cash Quality
2

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 42 quarters